Listenly

How does LegitScript treat websites that claim products are research-only while marketing them for human consumption?

Answered at 18:05 in Peptides, Telemedicine, Pharmacy & Compliance: The Future of Peptide Healthcare · B2B Vault: The Biz To Biz Podcast

— questions searchable right now

How does LegitScript treat websites that claim products are research-only while marketing them for human consumption?

LegitScript ignores disclaimers buried in fine print and instead examines what a website is actually selling. If the product label says "research use only" but the entire page discusses fat loss, recovery, anti-aging, or longevity, the mismatch between label and marketing content triggers a compliance failure. Regulators look at the intended actual use of the product, not the escape clause.

When the Label and the Pitch Tell Different Stories

A merchant cannot hide behind a single disclaimer while the rest of the website markets the product for human health outcomes. As Angela Salter explains in the episode, the intent of the seller matters far more than the fine print. If a customer reads about recovery benefits, anti-aging claims, or weight loss effects, the product is being marketed for human consumption—regardless of what the label technically states.

This approach reflects how regulatory bodies, including the FDA and FTC, actually interpret compliance. Intent is determined by the totality of the marketing message, not by a single protective line of text. A company cannot have it both ways: selling a product as if it works for human health while claiming research-only status to evade oversight.

"We certify based on current applicable laws and regulations, not what a committee thinks might be true in a year or two."

Angela Salter — Vice President of Enterprise Certification Sales and Partnerships at LegitScript. Salter oversees enterprise customer onboarding and account management for LegitScript's certification program, which validates compliance for telemedicine, pharmacy, and supplement merchants. She also manages relationships with strategic partners including Visa, MasterCard, and ad platforms that require LegitScript certification, making her responsible for enforcing these standards across thousands of merchants.

Allen Kopelman on B2B Vault: The Biz To Biz PodcastAll answers from this podcast →
Full answer and detailsRead the whole answer, key facts and every other question from this episode

In short

LegitScript ignores disclaimers buried in fine print and instead examines what a website is actually selling.

Allen Kopelman · Peptides, Telemedicine, Pharmacy & Compliance: The Future of Peptide Healthcare · B2B Vault: The Biz To Biz Podcast · answer at 18:05

Key takeaways

  • If the product label says "research use only" but the entire page discusses fat loss, recovery, anti-aging, or longevity, the mismatch between label and marketing content triggers a compliance failure.
  • A merchant cannot hide behind a single disclaimer while the rest of the website markets the product for human health outcomes.
  • This approach reflects how regulatory bodies, including the FDA and FTC, actually interpret compliance.
  • Angela Salter — Vice President of Enterprise Certification Sales and Partnerships at LegitScript.

Quote to remember

“We certify based on current applicable laws and regulations, not what a committee thinks might be true in a year or two.”

— Allen Kopelman

The full answer · about 2 min

LegitScript ignores disclaimers buried in fine print and instead examines what a website is actually selling. If the product label says "research use only" but the entire page discusses fat loss, recovery, anti-aging, or longevity, the mismatch between label and marketing content triggers a compliance failure. Regulators look at the intended actual use of the product, not the escape clause.

When the Label and the Pitch Tell Different Stories

A merchant cannot hide behind a single disclaimer while the rest of the website markets the product for human health outcomes. As Angela Salter explains in the episode, the intent of the seller matters far more than the fine print. If a customer reads about recovery benefits, anti-aging claims, or weight loss effects, the product is being marketed for human consumption—regardless of what the label technically states.

This approach reflects how regulatory bodies, including the FDA and FTC, actually interpret compliance. Intent is determined by the totality of the marketing message, not by a single protective line of text. A company cannot have it both ways: selling a product as if it works for human health while claiming research-only status to evade oversight.

"We certify based on current applicable laws and regulations, not what a committee thinks might be true in a year or two."

Angela Salter — Vice President of Enterprise Certification Sales and Partnerships at LegitScript. Salter oversees enterprise customer onboarding and account management for LegitScript's certification program, which validates compliance for telemedicine, pharmacy, and supplement merchants. She also manages relationships with strategic partners including Visa, MasterCard, and ad platforms that require LegitScript certification, making her responsible for enforcing these standards across thousands of merchants.

More answers from this episode

 ·  All answers from B2B Vault: The Biz To Biz Podcast →
—
—
0:00
0:00